David W. Yandell

8.6k total citations · 1 hit paper
67 papers, 7.0k citations indexed

About

David W. Yandell is a scholar working on Oncology, Molecular Biology and Ophthalmology. According to data from OpenAlex, David W. Yandell has authored 67 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 26 papers in Molecular Biology and 20 papers in Ophthalmology. Recurrent topics in David W. Yandell's work include Cancer-related Molecular Pathways (34 papers), Ocular Oncology and Treatments (20 papers) and Cancer Genomics and Diagnostics (12 papers). David W. Yandell is often cited by papers focused on Cancer-related Molecular Pathways (34 papers), Ocular Oncology and Treatments (20 papers) and Cancer Genomics and Diagnostics (12 papers). David W. Yandell collaborates with scholars based in United States, Germany and Japan. David W. Yandell's co-authors include Thaddeus P. Dryja, John B. Little, Kenshi Hayashi, Terri L. McGee, Junya Toguchida, Glenn S. Cowley, Eliot L. Berson, Lauri B. Hahn, Elias Reichel and Michael A. Sandberg and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David W. Yandell

67 papers receiving 6.8k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A point mutation of the rhodopsin gene in one form of retinitis pigmentosa

1990 806 citations Thaddeus P. Dryja, Terri L. McGee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Yandell United States	38	3.9k	3.1k	1.2k	1.2k	954	67	7.0k
Martin van der Valk Netherlands	33	4.0k 1.0×	3.6k 1.2×	416 0.3×	703 0.6×	820 0.9×	45	6.9k
Jin‐Yuh Shew Taiwan	23	2.7k 0.7×	3.1k 1.0×	1.4k 1.1×	934 0.8×	1.1k 1.1×	32	5.2k
Earlene M. Schmitt United States	10	5.0k 1.3×	4.0k 1.3×	327 0.3×	1.1k 1.0×	613 0.6×	13	7.5k
Nelleke A. Gruis Netherlands	36	3.3k 0.8×	3.9k 1.3×	616 0.5×	1.7k 1.5×	614 0.6×	103	6.5k
Annelies de Klein Netherlands	52	5.2k 1.3×	1.9k 0.6×	1.9k 1.6×	786 0.7×	1.3k 1.3×	219	11.5k
Joan M. O’Brien United States	31	2.1k 0.5×	1.8k 0.6×	2.9k 2.3×	516 0.4×	385 0.4×	130	5.3k
H. Berna Beverloo Netherlands	50	5.3k 1.4×	1.7k 0.6×	293 0.2×	1.2k 1.0×	821 0.9×	125	9.4k
Marc‐Henri Stern France	43	3.5k 0.9×	2.4k 0.8×	931 0.8×	2.1k 1.8×	635 0.7×	149	6.5k
Dominique Stoppa‐Lyonnet France	47	3.9k 1.0×	2.3k 0.8×	341 0.3×	1.9k 1.7×	3.1k 3.3×	239	7.4k
David W. Goodrich United States	34	3.1k 0.8×	2.3k 0.7×	394 0.3×	788 0.7×	525 0.6×	97	5.0k

Countries citing papers authored by David W. Yandell

Since Specialization

Citations

This map shows the geographic impact of David W. Yandell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Yandell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Yandell more than expected).

Fields of papers citing papers by David W. Yandell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Yandell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Yandell. The network helps show where David W. Yandell may publish in the future.

Co-authorship network of co-authors of David W. Yandell

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Yandell. A scholar is included among the top collaborators of David W. Yandell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Yandell. David W. Yandell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barlow, John, David W. Yandell, Donald L. Weaver, Theresa Casey, & Karen Plaut. (2003). Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors. Breast Cancer Research and Treatment. 79(2). 149–159. 26 indexed citations

Shattuck, Trisha M., Teresa S. Kim, Jessica L. Costa, et al.. (2003). Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma. Clinical Endocrinology. 59(2). 180–189. 47 indexed citations

Kupryjańczyk, Jolanta, Agnieszka Dansonka‐Mieszkowska, T Szymańska, et al.. (2000). Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction. British Journal of Cancer. 82(3). 579–583. 11 indexed citations

Kato, Mitsuo, Takashi Shimizu, Kanji Ishizaki, et al.. (1996). Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma. Cancer Letters. 106(1). 75–82. 45 indexed citations

Poremba, Christopher, David W. Yandell, W. Mellin, et al.. (1995). Adenocarcinoma of the Cardia in a Young Man: Detection of Somatic p53 Mutation by Immunohistochemistry and Automated Direct Sequencing. Pathology - Research and Practice. 191(10). 1004–1009. 2 indexed citations

Ikeda, Hidetoshi, Roberta L. Beauchamp, Takashi Yoshimoto, & David W. Yandell. (1995). Detection of heterozygous mutation in the retinoblastoma gene in a human pituitary adenoma using PCR-SSCP analysis and direct sequencing. Endocrine Pathology. 6(3). 189–196. 8 indexed citations

Henson, John W., Andreas von Deimling, Hong‐Ji Xu, et al.. (1994). The retinoblastoma gene is involved in malignant progression of astrocytomas. Annals of Neurology. 36(5). 714–721. 179 indexed citations

Hiort, Olaf, George T. Klauber, Gernot H.G. Sinnecker, et al.. (1994). Molecular characterization of the androgen receptor gene in boys with hypospadias. European Journal of Pediatrics. 153(5). 317–321. 60 indexed citations

Rubio, Mari‐Paz, Andreas von Deimling, David W. Yandell, et al.. (1993). Accumulation of wild type p53 protein in human astrocytomas.. PubMed. 53(15). 3465–7. 119 indexed citations

10.

Spiro, Ira J., David W. Yandell, Chuan Li, et al.. (1993). Lymphoma of Donor Origin Occurring in the Porta Hepatis of a Transplanted Liver. New England Journal of Medicine. 329(1). 27–29. 64 indexed citations

11.

Hayashi, Kenshi & David W. Yandell. (1993). How sensitive is PCR-SSCP?. Human Mutation. 2(5). 338–346. 389 indexed citations

12.

Toguchida, Junya, Toshikazu Yamaguchi, Guillermo E. Herrera, et al.. (1992). Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma. New England Journal of Medicine. 326(20). 1301–1308. 227 indexed citations

13.

Wullich, Bernd, Jean M. Whaley, Guillermo A. Herrera, et al.. (1992). Cytogenetic and molecular studies of a familial renal cell carcinoma. Cancer Genetics and Cytogenetics. 63(1). 25–31. 6 indexed citations

14.

Brachman, David, Everett E. Vokes, Michael A. Beckett, et al.. (1992). Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.. PubMed. 52(17). 4832–6. 187 indexed citations

15.

Rubin, Steven J., Dennis E. Hallahan, Charles R. Ashman, et al.. (1991). Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. Journal of Surgical Oncology. 46(1). 31–36. 102 indexed citations

16.

Brachman, David, et al.. (1991). p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.. PubMed. 51(23 Pt 1). 6393–6. 74 indexed citations

17.

McGee, Terri L., Glenn S. Cowley, David W. Yandell, & Thaddeus P. Dryja. (1990). Detection of theXbal RFLP within the retinoblastoma locus by PCR. Nucleic Acids Research. 18(1). 207–207. 34 indexed citations

18.

Yandell, David W., T Campbell, Robert A. Petersen, et al.. (1989). Oncogenic Point Mutations in the Human Retinoblastoma Gene: Their Application to Genetic Counseling. New England Journal of Medicine. 321(25). 1689–1695. 235 indexed citations

19.

Yandell, David W. & Thaddeus P. Dryja. (1989). Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing.. PubMed. 45(4). 547–55. 148 indexed citations

20.

McGee, Terri L., David W. Yandell, & Thaddeus P. Dryja. (1989). Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene. 80(1). 119–128. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact